These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33130829)

  • 1. The functional analysis of Cullin 7 E3 ubiquitin ligases in cancer.
    Shi L; Du D; Peng Y; Liu J; Long J
    Oncogenesis; 2020 Oct; 9(10):98. PubMed ID: 33130829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of CRL7
    Hopf LVM; Baek K; Klügel M; von Gronau S; Xiong Y; Schulman BA
    Nat Struct Mol Biol; 2022 Sep; 29(9):854-862. PubMed ID: 35982156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.
    Pan ZQ
    Adv Exp Med Biol; 2020; 1217():285-296. PubMed ID: 31898234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling.
    Scheufele F; Wolf B; Kruse M; Hartmann T; Lempart J; Mühlich S; Pfeiffer AFH; Field LJ; Charron MJ; Pan ZQ; Engelhardt S; Sarikas A
    Cell Signal; 2014 Feb; 26(2):233-239. PubMed ID: 24219910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the Cullin7 E3 ubiquitin ligase--heterodimerization of cullin substrate receptors as a novel mechanism to regulate cullin E3 ligase activity.
    Ponyeam W; Hagen T
    Cell Signal; 2012 Jan; 24(1):290-5. PubMed ID: 21946088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARC and CUL7 form atypical cullin RING ligase complexes.
    Skaar JR; Florens L; Tsutsumi T; Arai T; Tron A; Swanson SK; Washburn MP; DeCaprio JA
    Cancer Res; 2007 Mar; 67(5):2006-14. PubMed ID: 17332328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cullin 7 in tumor development: a novel potential anti-cancer target.
    Li Y; Zang A; Fu J; Jia Y
    Neoplasma; 2021 May; 68(3):572-579. PubMed ID: 33618520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.
    Wang H; Chen Y; Lin P; Li L; Zhou G; Liu G; Logsdon C; Jin J; Abbruzzese JL; Tan TH; Wang H
    J Biol Chem; 2014 Feb; 289(7):4009-17. PubMed ID: 24362026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cullin7 E3 ubiquitin ligase: a novel player in growth control.
    Sarikas A; Xu X; Field LJ; Pan ZQ
    Cell Cycle; 2008 Oct; 7(20):3154-61. PubMed ID: 18927510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRL7
    Shah VJ; Maddika S
    J Cell Sci; 2018 Apr; 131(8):. PubMed ID: 29507117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fbxw8 is essential for Cul1-Cul7 complex formation and for placental development.
    Tsunematsu R; Nishiyama M; Kotoshiba S; Saiga T; Kamura T; Nakayama KI
    Mol Cell Biol; 2006 Aug; 26(16):6157-69. PubMed ID: 16880526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen.
    Hartmann T; Xu X; Kronast M; Muehlich S; Meyer K; Zimmermann W; Hurwitz J; Pan ZQ; Engelhardt S; Sarikas A
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3371-6. PubMed ID: 24550499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.
    Furukawa M; He YJ; Borchers C; Xiong Y
    Nat Cell Biol; 2003 Nov; 5(11):1001-7. PubMed ID: 14528312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates Golgi morphology and dendrite patterning.
    Litterman N; Ikeuchi Y; Gallardo G; O'Connell BC; Sowa ME; Gygi SP; Harper JW; Bonni A
    PLoS Biol; 2011 May; 9(5):e1001060. PubMed ID: 21572988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation.
    Xu X; Sarikas A; Dias-Santagata DC; Dolios G; Lafontant PJ; Tsai SC; Zhu W; Nakajima H; Nakajima HO; Field LJ; Wang R; Pan ZQ
    Mol Cell; 2008 May; 30(4):403-14. PubMed ID: 18498745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic ablation of Cullin-RING E3 ubiquitin ligase 7 restrains pressure overload-induced myocardial fibrosis.
    Anger M; Scheufele F; Ramanujam D; Meyer K; Nakajima H; Field LJ; Engelhardt S; Sarikas A
    PLoS One; 2020; 15(12):e0244096. PubMed ID: 33351822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function.
    Andrews P; He YJ; Xiong Y
    Oncogene; 2006 Aug; 25(33):4534-48. PubMed ID: 16547496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase.
    Pintard L; Willis JH; Willems A; Johnson JL; Srayko M; Kurz T; Glaser S; Mains PE; Tyers M; Bowerman B; Peter M
    Nature; 2003 Sep; 425(6955):311-6. PubMed ID: 13679921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel p53-binding domain in CUL7.
    Kasper JS; Arai T; DeCaprio JA
    Biochem Biophys Res Commun; 2006 Sep; 348(1):132-8. PubMed ID: 16875676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
    Iwai K; Yamanaka K; Kamura T; Minato N; Conaway RC; Conaway JW; Klausner RD; Pause A
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12436-41. PubMed ID: 10535940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.